Literature DB >> 11136353

Heart rate variability in patients with untreated Parkinson's disease.

M Kallio1, T Haapaniemi, J Turkka, K Suominen, U Tolonen, K Sotaniemi, V P Heikkilä, V Myllylä.   

Abstract

The aim of this study was to evaluate cardiovascular responses as a marker of autonomic nervous system (ANS) disturbances in patients with untreated Parkinson's disease (PD) and to assess the relationship between them and the clinical characteristics of PD. The ANS functions were investigated in 50 patients with PD and 55 healthy subjects by measuring standard cardiovascular autonomic reflexes and heart rate variability (HRV) at rest using spectral analysis (the autoregressive model and the fast Fourier transformation), the percentage of the counts of beat-to-beat variation greater than 50 ms and the fractal dimension. Significantly attenuated HRV and deficient blood pressure reaction to tilting were found in the PD patient group. The patients with hypokinesia/rigidity as the initial symptom of PD had a more pronounced HRV deficit than those with tremor onset. Untreated PD patients suffer significant failure in cardiovascular nervous system regulation, and in patients with hypokinesia/rigidity as their initial disease manifestation the risk of this ANS dysfunction is high. However, in the early stages of PD these changes did not reach significance at individual level.

Entities:  

Mesh:

Year:  2000        PMID: 11136353     DOI: 10.1046/j.1468-1331.2000.00127.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  37 in total

1.  Comparison of heart rate variability analysis methods in patients with Parkinson's disease.

Authors:  M Kallio; K Suominen; A M Bianchi; T Mäkikallio; T Haapaniemi; S Astafiev; K A Sotaniemi; V V Myllyä; U Tolonen
Journal:  Med Biol Eng Comput       Date:  2002-07       Impact factor: 2.602

2.  Parasympathetic but not sympathetic cardiac dysfunction at early stages of Parkinson's disease.

Authors:  Axel Buob; H Winter; M Kindermann; G Becker; J C Möller; W H Oertel; M Böhm
Journal:  Clin Res Cardiol       Date:  2010-05-05       Impact factor: 5.460

3.  Cardiovascular variability in Parkinson's disease and extrapyramidal motor slowing.

Authors:  Rachael Brown; Stephen Duma; Olivier Piguet; G Anthony Broe; Vaughan G Macefield
Journal:  Clin Auton Res       Date:  2012-04-25       Impact factor: 4.435

Review 4.  Concepts of scientific integrative medicine applied to the physiology and pathophysiology of catecholamine systems.

Authors:  David S Goldstein
Journal:  Compr Physiol       Date:  2013-10       Impact factor: 9.090

Review 5.  Are sleep disturbances preclinical markers of Parkinson's disease?

Authors:  Altair B dos Santos; Kristi A Kohlmeier; George E Barreto
Journal:  Neurochem Res       Date:  2014-11-30       Impact factor: 3.996

Review 6.  'The clocks that time us'--circadian rhythms in neurodegenerative disorders.

Authors:  Aleksandar Videnovic; Alpar S Lazar; Roger A Barker; Sebastiaan Overeem
Journal:  Nat Rev Neurol       Date:  2014-11-11       Impact factor: 42.937

7.  mHealth and wearable technology should replace motor diaries to track motor fluctuations in Parkinson's disease.

Authors:  M Kelley Erb; Daniel R Karlin; Bryan K Ho; Kevin C Thomas; Federico Parisi; Gloria P Vergara-Diaz; Jean-Francois Daneault; Paul W Wacnik; Hao Zhang; Tairmae Kangarloo; Charmaine Demanuele; Chris R Brooks; Craig N Detheridge; Nina Shaafi Kabiri; Jaspreet S Bhangu; Paolo Bonato
Journal:  NPJ Digit Med       Date:  2020-01-17

Review 8.  Circadian and sleep disorders in Parkinson's disease.

Authors:  Aleksandar Videnovic; Diego Golombek
Journal:  Exp Neurol       Date:  2012-08-23       Impact factor: 5.330

Review 9.  Circadian dysfunction may be a key component of the non-motor symptoms of Parkinson's disease: insights from a transgenic mouse model.

Authors:  L David Willison; Takashi Kudo; Dawn H Loh; Dika Kuljis; Christopher S Colwell
Journal:  Exp Neurol       Date:  2013-01-24       Impact factor: 5.330

10.  Increased markers of cardiac vagal activity in leucine-rich repeat kinase 2-associated Parkinson's disease.

Authors:  Claudia Carricarte Naranjo; Connie Marras; Naomi P Visanji; David J Cornforth; Lazaro Sanchez-Rodriguez; Birgitt Schüle; Samuel M Goldman; Mario Estévez; Phyllis K Stein; Anthony E Lang; Herbert F Jelinek; Andrés Machado
Journal:  Clin Auton Res       Date:  2019-08-23       Impact factor: 4.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.